PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34914083-6	2022	Detection of ESBL production was carried out by using ESBL ChromoSelect Agar medium and the combined disk diffusion.	Agar	72-76	EsbL	Escherichia coli	13-17	
34756091-10	2021	CHROMagar extended-spectrum beta-lactamase (ESBL) agar supported growth of a wider diversity of extended-spectrum-cephalosporin-resistant E. coli strains.	Agar	50-54	EsbL	Escherichia coli	10-42	
34914083-6	2022	Detection of ESBL production was carried out by using ESBL ChromoSelect Agar medium and the combined disk diffusion.	Agar	72-76	EsbL	Escherichia coli	54-58	
27681363-3	2016	ESBL-producing E. coli was screened and confirmed by confirmatory test and E. coli-identifying agars.	Agar	95-100	EsbL	Escherichia coli	0-4	
33924433-4	2021	Extended-spectrum beta-lactamase (ESBL)-producing E. coli were isolated on deoxycholate hydrogen sulfide lactose agar, containing cephalexin (50 mug/mL) or cefotaxime (2 mug/mL), and were characterized with antimicrobial susceptibility testing, pulsed-field gel electrophoresis (PFGE), replicon typing, and beta-lactamase typing analyses.	Agar	113-117	EsbL	Escherichia coli	0-32	
33362749-4	2020	The total number of bacteria growing on the selective ChromID ESBL agar was 3.1 x 105 cfu/L (23.8% of all growing bacteria) in 2016, whereas it was 100-fold lower in 2017 (3 x 103 cfu/L; 8.3% of all growing bacteria).	Agar	67-71	EsbL	Escherichia coli	62-66	
33199763-5	2020	Recovery of isolates with multi-drug resistance (MDR) genotypes was lower from McC + CTX than ESBL agar.	Agar	99-103	EsbL	Escherichia coli	94-98	
32434784-9	2020	From ceca and water, potential ESBL E. coli were only confirmed from MacConkey agar with 4 mug/ml cefotaxime, where 45% and 16.6% of E. coli isolates phenotypically expressed ESBL-production.	Agar	79-83	EsbL	Escherichia coli	31-35	
31695911-4	2019	After screening using ESBL-selective agar plates and species identification by MALDI-TOF mass spectrometry, antibiotic susceptibility was tested using the disk diffusion method, and ESBL production confirmed with the double-disc synergy test.	Agar	37-41	EsbL	Escherichia coli	22-26	
31054921-5	2019	The ESBL-EC screening was performed by using MacConkey agar supplemented with cefotaxime.	Agar	55-59	EsbL	Escherichia coli	4-8	
26494113-2	2017	Intestinal colonisation by ESBL-producing Escherichia coli was detected in 23 nursing home residents (14.7%) using MacConkey agar supplemented with cefotaxime (1mg/L) for screening and the combined disc method for ESBL confirmation.	Agar	125-129	EsbL	Escherichia coli	27-31	
24292287-4	2013	The ESBL status was confirmed by double disc diffusion test (DDDT) and minimum inhibitory concentration (MIC) by agar dilution method by standard procedure.	Agar	113-117	EsbL	Escherichia coli	4-8	
25134392-3	2014	The aim of the present study was to evaluate the performance of Brilliance ESBL agar (Oxoid; Thermo Fisher Scientific, UK), a selective chromogenic agar for the detection of ESBL-producing Escherichia coli (E. coli) and Klebsiella pneumoniae (K. pneumoniae) strains.	Agar	80-84	EsbL	Escherichia coli	75-79	
25134392-3	2014	The aim of the present study was to evaluate the performance of Brilliance ESBL agar (Oxoid; Thermo Fisher Scientific, UK), a selective chromogenic agar for the detection of ESBL-producing Escherichia coli (E. coli) and Klebsiella pneumoniae (K. pneumoniae) strains.	Agar	80-84	EsbL	Escherichia coli	174-178	
23685466-2	2013	The presence of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli (E. coli) in raw poultry is one of the most common factors that interfere with the isolation of Campylobacter by cefoperazone-based selective agar.	Agar	225-229	EsbL	Escherichia coli	16-48	
23685466-2	2013	The presence of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli (E. coli) in raw poultry is one of the most common factors that interfere with the isolation of Campylobacter by cefoperazone-based selective agar.	Agar	225-229	EsbL	Escherichia coli	50-54	
20106863-2	2010	METHODS: Bacteria in stool specimens were screened for extended-spectrum beta-lactamase (ESBL) production on McConkey agar with cefotaxime and confirmed by the double-disc synergy test.	Agar	118-122	EsbL	Escherichia coli	55-87	
22826985-4	2012	ESBL phenotypic confirmatory test with ceftazidime, CTX and cefotaxime was performed for all urine isolates by disc diffusion method on Mueller-Hinton agar plates.	Agar	151-155	EsbL	Escherichia coli	0-4	
20367084-6	2010	Further, the occurrence of extended-spectrum beta-lactamase (ESBL)-producing E. coli isolates was estimated in the 54 fecal samples of ostriches using cefotaxime-supplemented Levine agar plates for ESBL-positive E. coli recovery.	Agar	182-186	EsbL	Escherichia coli	27-59	
20455405-9	2010	All (100%) of the 159 ESBL positive E. coli strains by DDS test were also found positive on chromID ESBL agar, and 150 (94.3%) were found positive on Drigalski agar.	Agar	105-109	EsbL	Escherichia coli	22-26